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Abstract
Background: Final infarct size following coronary occlusion is determined by the duration of ischemia, the size of 
myocardium at risk (MaR) and reperfusion injury. The reference method for determining MaR, single-photon emission 
computed tomography (SPECT) before reperfusion, is impractical in an acute setting. The aim of the present study was 
to evaluate whether MaR can be determined from the contrast enhanced myocardium using steady-state free 
precession (SSFP) cine cardiovascular magnetic resonance (CMR) performed one week after the acute event in ST-
elevation myocardial infarction (STEMI) patients with total coronary occlusion.
Results: Sixteen patients with STEMI (age 64 ± 8 years) received intravenous 99 m-Tc immediately before primary 
percutaneous coronary intervention. SPECT was performed within four hours. MaR was defined as the non-perfused 
myocardial volume derived with SPECT. CMR was performed 7.8 ± 1.2 days after the myocardial infarction using a 
protocol in which the contrast agent was administered before acquisition of short-axis SSFP cines. MaR was evaluated 
as the contrast enhanced myocardial volume in the cines by two blinded observers. MaR determined from the 
enhanced region on cine CMR correlated significantly with that derived with SPECT (r2 = 0.78, p < 0.001). The difference 
in MaR determined by CMR and SPECT was 0.5 ± 5.1% (mean ± SD). The interobserver variability of contrast enhanced 
cine SSFP measurements was 1.6 ± 3.7% (mean ± SD) of the left ventricle wall volume.
Conclusions: Contrast enhanced SSFP cine CMR performed one week after acute infarction accurately depicts MaR 
prior to reperfusion in STEMI patients with total occlusion undergoing primary PCI. This suggests that a single CMR 
examination might be performed for determination of MaR and infarct size.
Background
The extent of myocardial injury following myocardial
infarction (MI) is an important determinant of short and
long term prognosis [1]. Early reperfusion, either by
pharmacological thrombolysis or by primary percutane-
ous coronary intervention, is therefore mandatory for the
effective myocardial salvage [2,3]. The introduction of
reperfusion therapy has lead to considerable improve-
ment in the survival of patients with acute ST-elevation
MI (STEMI) [4]. Still many patients develop extensive
myocardial damage underlining the need for therapeutic
modalities that limit the extent of the final injury. The
development of such treatment is dependent on methods
that accurately determines the size of the jeopardized
myocardium at risk (MaR) and that are feasible to use in
patients presenting with STEMI.
MaR comprises both myocardial tissue that is irrevers-
ibly injured at the time of reperfusion and a viable border
zone of reversibly injured cells [5]. The difference
between MaR and infarct size is used to calculate the
myocardial salvage index which is a measurement of the
effectiveness of interventions that aim to reduce the
extent of the final myocardial infarct [6]. The reference
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method for determining MaR is single photon emission
computer tomography (SPECT) [7-9]. This method
requires injection of a labelled isotope before reperfusion
which, besides being difficult to accomplish in an acute
setting, may delay the time to the coronary intervention
and exposes the patient to additional radiation. These
factors clearly limit the use of SPECT in clinical trials and
illustrate the need for development of new methods to
determine MaR.
Cardiovascular magnetic resonance (CMR) has an
excellent in-plane spatial resolution, producing precise
measurement of infarct size [10,11] without exposing the
patient to ionizing radiation. In 2005 Laissy et al. evalu-
ated the diagnostic value of contrast enhanced (CE) time-
resolved balanced steady-state free precession (SSFP) in
the assessment of infarct size compared with late gadolin-
ium enhancement (LGE) sequences [12]. They found a
close correlation and concluded that "CE cine-SSFP
sequences should play a role in assessing necrotic and
jeopardized myocardium after acute MI". Experimental
[13-15] and clinical [16-19] studies suggest that MaR can
be detected with different T2-weighted CMR depicting
the initial oedema several days after the acute MI. T2-
weighted imaging for quantification of MaR was recently
validated in humans using myocardial perfusion SPECT
[20]. Alternatively, it has been suggested that unenhanced
T1-weighted images can be used to quantify oedema [21],
infarcted endocardial surface area (infarct-ESA) [22] or
single-shot dark blood-prepared SSFP [23] for potential
subsequent identification of MaR.
We used a modified CMR protocol in which gadolin-
ium contrast agent is injected just before SSFP-imaging is
commenced for LV volumes and function, which is an
important distinction from standardized methods [24].
Using this protocol we observed transmural contrast
enhancement seemingly representing the MaR on cine-
SSFP sequences. This CMR protocol would thereby have
the potential to determine MaR and infarct size in one
single examination performed several days after the acute
event if the observed transmural contrast enhancement
on SSFP images represents MaR.
This study therefore tested the hypothesis that the
observed contrast enhancement on cine SSFP one week
after an acute MI represents MaR by comparing it with
reference method myocardial perfusion SPECT obtained
before opening the coronary occlusion.
Materials and methods
Study Protocol
Sixteen consecutive patients, age 64 ± 8, with first time
STEMI admitted for primary percutaneous coronary
intervention (PCI) during the period February 2007 to
December 2008 when myocardial perfusion scintigraphy
was accessible and who fulfilled the inclusion and exclu-
sion criteria were enrolled. Twelve patients were included
at the Karolinska University Hospital and four at the
Lund University Hospital. Myocardial perfusion isotope
was mostly available during daytime, which limited the
inclusion rate. Data from the four patients from Lund
constitute part of an earlier published study [20]. Inclu-
sion criteria were: chest pain ≥ 30 minutes and ≤ 9 hours
duration, ST-elevation in at least two contiguous ECG
leads or left bundle branch block and a complete coro-
nary occlusion (TIMI flow grade 0) of the infarct-related
artery at the time of coronary angiography. Exclusion cri-
teria were prior history of MI, prior coronary artery by-
pass grafting, cardiogenic shock, known renal insuffi-
ciency, contraindications for CMR, permanent atrial
fibrillation. The study was approved by the independent
local ethics committee at each center. Written informed
consent was obtained from all patients. The protocol was
designed, conducted and analysed with Good Clinical
Practice regulation.
Coronary Angiography
Coronary angiography was performed to confirm com-
plete coronary occlusion in the infarct related artery and
coronary angioplasty was then performed according to
local standard procedures at the discretion of the individ-
ual physician. The intervention was completed by a coro-
nary angiogram to determine final TIMI grade flow.
SPECT
Prior to opening of the occluded vessel the patients
received a body weight-adjusted (350-700 MBq) iv injec-
tion of 99 mTc tetrofosmin (Amersham Health, Bucking-
hamshire, UK) or sestamibi (MIBI, Cardio-lite, Bristol
Myers Squibb, USA). Myocardial perfusion SPECT imag-
ing was performed within four hours to visualize and
quantify MaR using either of two dual-head cameras: GE
camera (Ventri, GE Healthcare) or Sopha camera (DST-
XL; Sopha Medical Vision, Bue Cedex, France). The
patients were placed in the supine position and imaged in
steps of 5.6 degrees using a 64 × 64 matrix, with a typical
pixel size of 5 × 5 mm and a slice thickness of 5 mm. The
reconstructed voxel size was 3 × 3 × 3 mm (Sopha) or 6.4
× 6.4 × 6.4 mm (GE). Image acquisition time was approx-
imately 15 min. Iterative reconstruction using maximum-
likelihood expectation maximization was performed with
a low-resolution Butterworth filter and a cut off fre-
quency set to 0.5 of Nyquist and an order of 5.0. No atten-
uation or scatter correction was applied and short-axis
images were reconstructed semi-automatically on the
respective workstation for each camera.
CMR
A standard clinical CMR protocol, except for the time of
administration of contrast, was scheduled to be per-
formed one week after the onset of symptoms. TimingSörensson et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:25
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was chosen at one week to avoid the early infarct phase
where a rapid decrease in infarct size has been reported
[25]. Two 1.5 T systems were used: Signa Excite Twin-
Speed (General Electric Healthcare, Waukesha, WI, USA)
or Philips Intera CV (Philips, Best, Nederlands). Eight-
(GE) and five-channel (Philips) cardiac-coil was used and
all patients were in the supine position with vector-ECG
monitoring. A bolus of gadolinium contrast agent (0.2
mmol/kg bodyweight (Omniscan, GE Healthcare, Nor-
way or Magnevist, Bayer Pharma, Berlin, Germany) was
given iv just before positioning the patient in the scanner.
The image protocol included scout images, localization of
the short axis and then covering the whole left ventricle
(LV) with retrospectively gated SSFP cines. The following
typical parameters on GE-scanner was used; SSFP (TE
1.58 ms, TR 3.61 ms, flip angle 60 degrees, 25 phases, 8
mm slice, no gap, matrix 226 × 226). LGE images were
acquired 15-20 minutes after contrast injection using an
inversion recovery gradient echo sequence (TE 3.3 ms,
TR 7.0 ms, TI 180-250 ms to null the myocardium, 8 mm
slice, no gap, matrix 256 × 192) and the same slice orien-
tation as cine SSFP images. Typical parameters on the
Philips scanner was; SSFP (TE 1.4 ms, TR 2.8 ms, flip
angle 60 degrees, 30 phases, 8 mm slice, matrix 160 ×
141). LGE images were acquired 15-20 minutes after con-
trast injection using inversion recovery gradient echo
sequence (TE 1.14 ms, TR, 3.8 ms, TI 180-250 ms, 8 mm
slice, no gap, matrix 240 × 180). Cardiac triggering was
set for diastole to reduce motion artefacts. Each slice was
obtained during end-expiratory breath holding. Two-,
three- and four chamber views were also obtained to con-
firm the findings.
Image analysis and evaluation
Analysis of myocardial perfusion SPECT defect for MaR
was performed off-line using freely available segmenta-
tion software (Segment v1.702; http://seg-
ment.heiberg.se)[26,27]. The automatic segmentation
finds the centerline through the left ventricular wall and
identifies the endo- and epicardium based on an individ-
ually estimated wall thickness and signal intensity values
within the image [28]. Manual adjustment of the auto-
matic delineation was sometimes required in the left ven-
tricular outflow region. The perfusion defect was
determined by an automated algorithm that considers
myocardium with <55% of normal counts as being isch-
emic [29]. MaR was quantified as % of the left ventricle.
CMR images were analysed off-line using the same
software Segment. End-diastolic and end-systolic vol-
umes, ejection fraction, stroke volume and left ventricu-
lar volume was calculated on SSFP cines. The contrast
enhanced myocardial volume in SSFP cines was manually
delineated in end-diastole and end- systole by two
observers blinded to each other's findings and to SPECT
results. The values were averaged for internal control and
expressed as % of the LV wall volume. See additional file
1: Movie1 for the original data used to perform this analy-
sis. The relatively low contrast difference between con-
trast in injured myocardium and remote myocardium
precluded the use of a semi-quantification algorithm.
Infarction was quantified, in a later session, using an
automated quantification method [30] that has been vali-
dated in ex vivo and in vivo experiment in which partial
volume effects are accounted for.
To determine the image relative intensity ratio between
enhanced and remote myocardium a region of interest
(ROI) was manually drawn in approximately 80% of the
enhanced area in three consecutive slices and the same
size ROI was drawn in the remote myocardium.
Cardiac enzymes
Cardiac biomarkers were sampled every fourth hour after
admission on day one and every sixth hour on day two.
Troponin-T was analysed with immunoassay technique
(Modular Analytics E-module, Roche Diagnostics) and
CK-MB was analysed using chemical luminescence tech-
nique (UniCel DxI 800, Beckman Coulter AB).
Statistics
All data are expressed as mean and standard deviation.
Wilcoxon Mann-Whitney Rank Sum test was used to test
for differences between groups (SPECT and contrast
enhanced SSFP). Wilcoxon Sign Rank test was used to
test the relative signal enhancement in contrast enhanced
regions on SSFP images compared to remote myocar-
dium. Bland-Altman plots were constructed for compar-
ing contrast enhanced cine SSFP images with reference
standard myocardial perfusion SPECT. Interobserver
variability was calculated as the standard deviation of the
difference between two blinded observers divided by the
average of the two observers. A two-sided P-value < 0.05
was considered statistically significant. Statistical analysis
was performed using commercially available software
GraphPad Prism version 5.00 for Windows (GraphPad
Software, San Diego, CA, USA, http://www.graph-
pad.com). The authors had full access to the data and take
responsibility for its integrity. All authors have read and
agreed to the manuscript as written.
Results
Patients
The culprit lesion was located in the right coronary artery
(RCA) in twelve patients, in the left anterior descending
artery (LAD) in two and in the left circumflex artery
(LCx) in one (Table 1). All patients received oral anti-
platelet therapy with loading doses of 320-500 mg aspirin
and 300 or 600 mg clopidogrel before the intervention
and iv infusion of a GPIIb/IIIa inhibitor in connectionSörensson et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:25
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Table 1: Myocardium at risk comparing SPECT and CMR. Infarct size measured with LGE and myocardial salvage index
Culprit lesion MaR SPECT 
(LV%)
MaR CMR (LV%) Infarct size LGE 
(LV%)
Salvage Index 
(%)
Patient 1 RCA 38 31 15 52
Patient 2 LAD 51 47 30 36
Patient 3 RCA 30 35 1 97
Patient 4 RCA 30 30 9 70
Patient 5 RCA 31 28 14 50
Patient 6 RCA 15 23 2 91
Patient 7 LAD 37 32 11 66
Patient 8 RCA 26 24 9 63
Patient 9 RCA 25 21 9 57
Patient 10 RCA 28 29 7 76
Patient 11 RCA 11 17 10 41
Patient 12 RCA 26 24 10 58
Patient 13 RCA 14 23 5 78
Patient 14 RCA 18 24 9 63
Patient 15 CX 28 27 9 67
Patient 16 RCA 22 27 1 96
RCA = right coronary artery; LAD = left ascending artery; CX = left circumflex artery;
MaR = Myocardium at Risk; SPECT = single-photon emission computed tomography;
CMR = cardiovascular magnetic resonance; LV = left ventricle. Myocardial salvage index
(1-scar/MaR).
Figure 1 Agreement between MaR determined by CMR and SPECT. Panel A: Scatter plot showing MaR one week after reperfusion determined 
by gadolinum enhanced SSFP cines plotted versus MaR as it was before reperfusion determined by myocardial perfusion SPECT together with best 
line and line of identity. Panel B: Bland-Altman plot showing the agreement between MaR determined by myocardial perfusion SPECT and contrast 
enhanced cine SSFP. The difference was 0.5 ± 10% (mean ± 2SD).
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with the PCI procedure. TIMI flow grade 3 was achieved
in the affected artery in all patients. The time from onset
of chest pain to reperfusion was 222 ± 120 minutes. The
maximum levels of troponin-T and CK-MB were 7.0 ± 5.6
μg/l and 252 ± 210 μg/l, respectively. There were no
severe adverse events or reinfarctions prior to the CMR
investigation that was performed 7.8 ± 1.2 days after the
onset of symptoms.
CMR & SPECT
Images of good diagnostic quality were obtained in all
patients. Throughout the entire RR-interval a high trans-
mural signal was consistently observed in the infarct
region, and the infarct was always within the area of con-
trast enhancement in the SSFP cines. MaR, defined as the
non-perfused myocardial volume on SPECT, ranged from
11 to 51% (mean 27 ± 10%) of the LV wall volume. The
contrast enhanced region on SSFP cines, calculated as the
mean values obtained at end-diastole and end-systole,
ranged from 17 to 47% (mean 27 ± 7%) of the LV wall vol-
ume. As illustrated in Figure 1A there was a good correla-
tion between MaR determined from the enhanced region
on SSFP cines and that determined with SPECT (r2 =
0.78, p < 0.001). The difference between the enhanced
region on SSFP cines and MaR on SPECT was 0.5 ± 5.1%
(p = 0.60, Figure 1B). The location of the enhanced region
on SS FP cines alwa ys agreed wit h MaR on m yocar dial
perfusion SPECT images. Two typical examples of MaR
and infarct area in the RCA and LAD regions are shown
in Figures 2 and 3. The signal intensity ratio between
regions of gadolinium enhanced and remote myocardium
was 1.42 ± 0.25 (p < 0.001). The interobserver variability
for gadolinium enhanced myocardium between two read-
ers was 1.6 ± 3.7%. Infarct size determined by CMR
ranged from 1 to 30% (mean 9 ± 7%) of LV wall volume
and mean transmurality ranged from 26 to 52%.
Discussion
This study demonstrates that the contrast enhanced myo-
cardium on SSFP cines represents the MaR as deter-
mined by myocardial perfusion SPECT. Thus gadolinium
enhanced CMR performed one week after an acute
STEMI can accurately determine MaR simultaneously
with the infarct size.
The extent of the final infarct size is dependent on sev-
eral factors including the duration of ischemia, the degree
of collateral flow, myocardial oxygen demand and the size
of MaR [1]. In studies aimed at limiting infarct size, accu-
rate determination of MaR is crucial in order to calculate
the myocardial salvage index (Figure 4). The reference
standard method for determination of MaR is SPECT
which has the important limitation that the isotope needs
to be prepared and injected before the ischemic myocar-
dium is reperfused. Since isotope for SPECT may not be
readily available in the acute setting of primary PCI, new
methods which are more feasible to use in patients with
acute MI need to be developed.
Our results differ from those of an earlier study in 2005
where there was a good correlation between gadolinium
Figure 2 Inferior STEMI. Corresponding left ventricular short axis 
views from a patient with inferior STEMI. MaR determined by (a) myo-
cardial perfusion SPECT, (b) gadolinium enhanced SSFP at end-diasto-
le, (c) infarct size images with LGE and (d) gadolinium enhanced SSFP 
at end-systole.
ab
c d
Figure 3 Anterior STEMI. Corresponding left ventricular short axis 
views from a patient with anterior myocardial STEMI. MaR determined 
by (a) myocardial perfusion SPECT, (b) gadolinium enhanced SSFP at 
end-diastole, (c) infarct size images with LGE and (d) gadolinium en-
hanced SSFP at end-systole. It is clearly seen that the region of gado-
linium enhancement does not correspond in size or endocardial 
extent to the region of myocardium at risk either by SSFP cines or myo-
cardial SPECT.
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SSFP cines and infarct size on LGE [12]. These differ-
ences may in part be attributable to differences in study
populations with less transmural enhancement on gado-
linium SSFP cines in the present study likely due to
shorter pain-to-opening times Another possible explana-
tion may be that our study included only STEMI patients.
Previous attempts to investigate MaR through CMR
focused on different T2-weighted sequences. It was sug-
gested that MaR can be estimated using T2-weighted
imaging with short inversion time inversion-recovery
(STIR) or T2-prepared single-shot SSFP or a combination
of both [13,17,18,22]. The mechanism is not fully known
but oedema caused by the transient ischemia, cellular
swelling and impaired microvascular reperfusion have
been suggested [31]. T2-weighted imaging to quantify
MaR was first validated in humans using myocardial per-
fusion SPECT as reference [20]. The ACUT2E TSE-SSFP
study recently showed promising results by using a hybrid
m e t h o d  o f  T 2 - w e i g h t i n g  w i t h  b r i g h t - b l o o d  c o n t r a s t  i n
dogs [15].
The presently described technique also has the advan-
tage of sequentially determining MaR and the final infarct
size with excellent spatial resolution in one single exami-
nation. Since SSFP cines are available on all CMR-scan-
ners, MaR assessed by gadolinium SSFP cines might be
used as a robust independent complement in cases where
T2-weighted imaging may be difficult or subjected to
artefact problems. Fewer acquisitions would be required
since the volumetric dataset for MaR would be acquired
during the normal cine acquisitions for cardiac mass and
function.
The mechanism behind the enhanced myocardium
observed using gadolinium SSFP cines and the gadolin-
ium kinetics is not clarified by the present investigation
and needs to be investigated in further studies. The bal-
anced cine SSFP sequence is known to generate T2/T1-
weighting. Bright signal is due to short T1- or long T2-
relaxation or a combination of the two. Gadolinium
based contrast agents such as Gd-DTPA increases the
relaxation rates by approximately the same amount. On a
percentage basis, Gd-DTPA alters the T1-relaxation to a
much larger extent than T2-relaxation, since T1 in tissue
is much longer than T2 [32]. With an increased concen-
tration of contrast medium in the MaR, an increase in
signal would be seen from early balanced cine SSFP
echoes (i.e. proton spins that have not experienced T2-
relaxation), while signal originating from subsequent
echoes (i.e. proton spins that have experienced T2-relax-
ation) would remain approximately constant. As seen in
the studies using T2-weighted sequences to estimate
MaR, the bright signal seen in MaR is largely due to the
prolonged T2-relaxation of the oedema. This is most
likely the case using balanced cine SSFP as well, but the
signal is "boosted" by the shortening of T1-relaxation in
the MaR.
The present results are of potential clinical and scien-
tific importance because it provides an easily accessible
technique for quantification of the efficacy of reperfusion
therapy by calculation of the myocardial salvage index
[33]. The estimation of MaR and final infarct size might
be achieved in a stable patient situation several days after
the acute MI. This is in contrast to SPECT which requires
preparation and injection of isotope before reperfusion
and image acquisition within a few hours in an unstable
patient.
Limitations
The low number of patients may be seen as a limitation to
this study. On the other hand the material includes a large
span of myocardium at risk ranging from 11-51% of the
LV wall volume, which is important for the evaluation.
We did not use a semi-quantitative method to determine
the contrast enhanced myocardium on SSFP cines due to
the relatively low signal increase compared to remote
Figure 4 Myocardial salvage. Corresponding left ventricular short axis views from a patient with inferior STEMI. MaR determined by (a) gadolinium 
enhanced SSFP at end-diastole, (b) infarct size images with LGE and (c). The infarcted area from panel b is superimposed on MaR from panel a (light 
grey shade on dark striped area). Myocardial salvage index is calculated as (1-scar/MaR).
ab cSörensson et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:25
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myocardium. No comparison was made to T2-weighted
sequences because of low number of patients and that it
was not the objective with this study. Other limitations
are that only four out of sixteen patients were female,
most infarctions involved the RCA territory and only
total coronary occlusions (TIMI flow grade 0) were
included.
Conclusions
Contrast enhanced SSFP cines performed one week after
the acute event accurately depicts MaR as it was before
reperfusion in STEMI patients with total occlusion
undergoing primary PCI. A single CMR examination can
thereby be performed for determination of MaR and
infarct size.
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